MedPath

Steve N Caritis Md

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

3

Active:0
Completed:0

Trial Phases

2 Phases

Phase 1:1
Phase 2:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Phase 1
1 (50.0%)
Phase 2
1 (50.0%)

17-OHPC in Pregnancy: IM vs SC Routes

First Posted Date
2019-12-03
Last Posted Date
2023-08-03
Lead Sponsor
Steve N. Caritis, MD
Target Recruit Count
24
Registration Number
NCT04183452
Locations
🇺🇸

Christiana Care, Newark, Delaware, United States

🇺🇸

Duke University Medical Center, Durham, North Carolina, United States

🇺🇸

Wake Forest Baptist Medical Center, Winston-Salem, North Carolina, United States

and more 1 locations

Pharmacologically-based Strategies for Opioid Substitution Therapy During Pregnancy

Phase 2
Terminated
Conditions
Pregnancy
Opiate Addiction
Interventions
Drug: Frequency Group
Drug: Magnitude Group
First Posted Date
2019-02-05
Last Posted Date
2024-08-29
Lead Sponsor
Steve N. Caritis, MD
Target Recruit Count
13
Registration Number
NCT03831113
Locations
🇺🇸

Univerity of Pittsburgh Magee-Womens Hospital, Pittsburgh, Pennsylvania, United States

🇺🇸

High Risk Obstetrical Consultants, Knoxville, Tennessee, United States

Relationship Between Plasma Concentration of Hydroxyprogesterone Caproate (17-OHPC) and Preterm Birth

Phase 1
Terminated
Conditions
Preterm Birth
Interventions
First Posted Date
2017-09-26
Last Posted Date
2023-10-23
Lead Sponsor
Steve N. Caritis, MD
Target Recruit Count
159
Registration Number
NCT03292731
Locations
🇺🇸

Northwestern University, Chicago, Illinois, United States

🇺🇸

University of Pittsburgh-Magee Womens Hospital, Pittsburgh, Pennsylvania, United States

🇺🇸

University of Texas Medical Branch, Galveston, Texas, United States

and more 2 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.